Icelandic healthcare spend up 17% in 2008 – soon a gauge of global austerity?
This article was originally published in Clinica
Iceland spent over IKr109bn ($963m) on healthcare in 2008, up 17.1% on the IKr93.3bn of the previous year, the treasury revealed this week. Spending in 2007 had also risen by 8.6% on the IKr86bn of 2006.
You may also be interested in...
Teva plans to begin appeal proceedings, the firm has told Generics Bulletin, after being fined €60.5m ($72m) by the European Commission over an historic “pay-for-delay” arrangement covering subsidiary firm Cephalon’s Provigil (modafinil).
SK set for Korean trial with vaccine, as Biological E begins human trials of Baylor vaccine. Meanwhile, DongWha gets a Phase II nod for potential drug, and Celltrion progesses with Phase II regdanvimab trial.
UK start up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country.